XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Authority Hl7

42,405 resources

By Version

R2: 0
R2B: 0
R3: 2,217
R4: 26,023
R4B: 2,734
R5: 11,207
R6: 224

By Realm

none: 3,411
au: 272
be: 387
ca: 138
ch: 1,482
cl: 469
cr: 45
cz: 384
de: 190
dk: 88
ee: 155
eu: 1,173
fi: 87
fr: 120
in: 29
it: 181
kr: 5
nl: 929
no: 26
nz: 79
pl: 83
se: 22
stt: 116
us: 17,481
uv: 14,773
vn: 107
other: 7

Start Prev Rows 27200 - 27400 Next

Package	Version	Identity	Name/Title	Status	Date	Realm
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.505	Toxic Shock Syndrome (TSS) (Disorders) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.507	Toxic Shock Syndrome (TSS) (Disorders) (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.512	Brucellosis (Tests for Brucella species Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.515	Brucellosis (Tests for Brucella species Antibody [Quantitative])	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.516	Brucellosis (Organism or Substance in Lab Results)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.519	Dengue Virus Infection (Tests for dengue virus Nucleic Acid)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.523	Dengue Virus Infection (Tests for dengue virus Antigen)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.524	Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative])	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.525	Dengue Virus Infection (Tests for dengue virus IgM Antibody)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.527	Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative])	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.530	Borrelia species (Tests for Nucleic Acid)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.531	Lyme Disease (Tests for Borrelia burgdorferi IgM IgG Antibody by Immunoblot)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.532	Lyme Disease (Tests for Borrelia burgdorferi Antibody by Immunoassay)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.534	Smallpox (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.548	St. Louis Encephalitis Virus Infection (Tests for Saint Louis encephalitis virus Antibody [Qualitative])	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.550	Syphilis (Tests for Treponema pallidum Nucleic Acid)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.553	Anaplasma species (Tests by Microscopic Observation)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.555	Yellow Fever (Tests for yellow fever virus Nucleic Acid)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.557	Yellow Fever (Tests for yellow fever virus Antibody [Quantitative])	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.56	Diarrhea (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.560	West Nile Virus Infection (Tests for West Nile virus Nucleic Acid)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.569	Plague (Tests for Yersinia pestis Nucleic Acid)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.58	Pertussis (Tests for Bordetella pertussis Nucleic Acid)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.595	Tularemia (Tests for Francisella tularensis Nucleic Acid)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.598	Tularemia (Tests for Francisella tularensis Antibody)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.6	Diphtheria (Disorders) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.605	Organisms (Tests by Microscopic Observation by Acid Fast Stain)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.606	Tuberculosis (Organism or Substance in Lab Results)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.614	Pertussis (Tests for Bordetella pertussis Toxin Antibody)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.621	Inspiratory Whoop (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.632	Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.645	Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Nucleic Acid)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.648	Vomiting (ICD10CM)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.650	Jaundice (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.652	Bacteria (Tests in Specimen from Normally Sterile Site by Culture and Identification Method)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.660	Hypertonia [Excluding Congenital Hypertonia] (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.662	Chest Pain (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.663	Erythema Nodosum (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.664	Congenital Zika Syndromes (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.665	Congenital Zika Syndromes (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.666	Guillain Barré syndrome (Disorders) (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.668	Rash (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.671	Fever (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.672	Arthralgia (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.673	Arthralgia (ICD10CM)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.674	Conjunctivitis (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.675	Conjunctivitis (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.676	Pregnant (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.677	Postpartum (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.678	Postpartum (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.679	Hearing Loss (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.680	Abdominal Pain (ICD10CM)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.681	Abdominal Pain (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.686	Erythema Multiforme (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.687	Myalgia (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.689	Periorbital Edema (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.691	Eosinophilia (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.692	Eosinophilia (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.70	Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.702	Weight Loss (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.705	Syphilis (Tests for Treponemal or Non Treponemal Antibody)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.709	Cough [Non Productive] (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.71	Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.711	Wound Infection (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.712	Pneumonia (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.713	Sepsis [Septicemia] [Unspecified Organism] (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.714	Sepsis [Septicemia] [Unspecified Organism] (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.715	Meningitis (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.717	Cellulitis (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.718	Cellulitis (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.719	Myositis [Unspecified Cause] (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.720	Myositis [Unspecified Cause] (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.721	Otitis Media (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.722	Otitis Media (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.723	Otitis Externa (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.724	Otitis Externa (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.727	Acute Upper Respiratory Illness (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.728	HIV Infection (Tests for HIV Nucleic Acid [Qualitative])	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.730	HIV Infection (Tests for HIV Antibody)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.733	Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.744	Coccidioidomycosis (Tests for Coccidioides species IgG Antibody)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.746	Treponema pallidum (Tests by Microscopic Observation)	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.750	Chest Pain (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.755	Acute Upper Respiratory Illness (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.756	Purpura (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.757	Muscle Spasms (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.758	Muscle Spasms (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.762	Mumps (Test Panels for mumps virus IgM IgG Antibody)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.763	Parotitis [Unspecified Cause] (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.764	Mumps (Tests for mumps virus IgG Antibody)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.765	Aseptic Meningitis (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.766	Encephalitis (Disorders) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.767	Hearing Loss (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.770	Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid in Specimen from Normally Sterile Site)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.773	Invasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae Nucleic Acid in Specimen from Normally Sterile Site)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.777	Mastitis (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.779	Pancreatitis (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.780	Pancreatitis (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.782	Rubella (Test Panels for rubella virus IgM IgG Antibody)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.785	Opioid Overdose and Poisoning (Tests for Opioids [Qualitative])	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.789	Purpura (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.79	Campylobacteriosis (Disorders) (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.792	Novel Influenza A Virus Infection (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.793	Novel Influenza A Virus Infection (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.794	Sore Throat (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.795	Influenza (influenza A virus in Lab Results)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.796	Influenza (Novel influenza A virus in Lab Results)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.797	Influenza (Tests for influenza A or B virus by Culture and Identification Method)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.798	Influenza (Tests for influenza A virus Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.799	Influenza (Tests for influenza A virus Antigen)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.802	Influenza (Tests for Novel influenza A virus Nucleic Acid)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.803	Tests by Microscopic Observation in Tissue by H&E or PAS Stain	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.808	Headache (ICD10CM)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.809	Headache (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.810	Backache (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.811	Backache (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.815	NU_Anaplasmosis (Tests for Anaplasma species Antibody [Qualitative])	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.816	Rubella (Tests for rubella virus IgG Antibody [Ratio] in Serum)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.818	Measles (Tests for measles virus IgG Antibody [Ratio] in Serum)	active	2025-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.820	Rubella (Tests for rubella virus IgG Antibody [Quantitative] in Serum)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.822	Pneumoconiosis (Unspecified) (ICD10CM)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.823	Pneumoconiosis (Unspecified) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.824	Computerized Tomography of Chest (Imaging)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.830	Poliovirus Infection (Tests for Poliovirus Antibody Titer in Serum Specimen)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.835	Lead in Blood (Disorders) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.836	Lead in Blood (Disorders) (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.839	Acid Fast Bacilli (Organism or Substance in Lab Results)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.841	Tuberculosis (Interferon Gamma Release Assays)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.842	Tests by Microscopic Observation in Tissue	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.846	SARS (Tests for SARS_CoV by Culture and Identification Method)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.847	SARS (Tests for SARS_CoV Nucleic Acid)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.86	Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.864	Nausea (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.865	Confusion (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.867	Dyspnea (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.869	Loss of Consciousness (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.87	Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.875	SARS (Organism or Substance in Lab Results)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.878	MERS (Tests for MERS_CoV Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.88	Hemolytic Uremic Syndrome (HUS) (Disorders) (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.881	Difficulty Breathing (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.884	Tests by Microscopic Observation in Blood	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.889	Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.892	Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.895	Rhinorrhea (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.896	Tests by Microscopic Observation in Blood Smear	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.897	Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.9	Xray of Chest (Imaging)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.90	Cough (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.902	Acute Renal Failure [Unspecified Cause] (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.907	Arthritis [Unspecified Cause] (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.91	Cough (SNOMED)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.910	Epididymitis [Unspecified Cause] (SNOMED)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.911	Epididymitis [Unspecified Cause] (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.914	Osteomyelitis [Unspecified Cause] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.915	Osteomyelitis [Unspecified Cause] (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.918	Spondylitis [Unspecified Cause] (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.919	Arthritis [Unspecified Cause] (ICD10CM)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.92	Thrombotic Thrombocytopenic Purpura (TTP) (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.927	Thrombocytopenia [Unspecified Cause] (ICD10CM)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.928	Bleeding [Unspecified Cause] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.930	ECG Abnormalities [Unspecified Cause] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.931	Hematemesis [Unspecified Cause] (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.932	Hematemesis [Unspecified Cause] (ICD10CM)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.934	Hematuria [Unspecified Cause] (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.935	Hemoptysis (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.937	Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.942	Petechiae [Non Traumatic] (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.952	Thrombocytopenia [Unspecified Cause] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.956	Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.957	Regional Lymphadenitis [Including Bubo] (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.958	Regional Lymphadenitis (ICD10CM)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.965	Proteinuria [Unspecified Cause] (ICD10CM)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.969	Proteinuria [Unspecified Cause] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.970	Bulbar Weakness (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.971	Bulbar Weakness (ICD10CM)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.976	Dysphagia (SNOMED)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.978	Impaired Respiration [Unspecified Cause] (SNOMED)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.979	Botulism (Organism or Substance in Lab Results)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.98	Shigellosis (Disorders) (SNOMED)	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.989	Tests for Mycobacterium species by Culture and Identification Method	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.994	Organisms (Tests for Nucleic Acid)	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.998	Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.999	Chlamydia species (Organism or Substance in Lab Results)	active	2023-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.109	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.110	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.112	Pressure Injury Deep Tissue	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.113	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2022-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.122	Inpatient Falls	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.130	Anticoagulants for VTE Prophylaxis	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.131	Anticoagulants for Indications Other than VTE Prophylaxis	active	2024-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.160	Abdominal or Pelvic CT Scan with Contrast	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.163	Ultrasound of Lower Extremities	active	2024-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.164	Ultrasound of Lower Extremities	active	2024-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.165	Ultrasound of Lower Extremities	active	2024-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.171	Inpatient Falls	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.183	Anti Factor Xa Assay	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.187	Extracorporeal Membrane Oxygenation (ECMO)	active	2022-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.188	Extracorporeal Membrane Oxygenation (ECMO)	active	2022-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.190	Intra Aortic Balloon Pump	active	2022-04	us